Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FU5QY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,195
Award facts
- Contract value 100% obligated
- $12,194.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $12,194.93 firm fixed-price delivery order on August 29, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of September 2, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the company's role as a critical pharmaceutical distributor for federal medical procurement.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency's Medical Supply Chain. The SPE2DX contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a vast range of medications and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Trulicity delivery order exemplifies the company's routine fulfillment of diabetes medications and other therapeutic pharmaceuticals under the broader prime vendor agreement, demonstrating AmerisourceBergen's capability to meet federal medical supply requirements through competitively awarded contracts.
Quick answers
Who was awarded contract SPE2DB25FU5QY?
SPE2DB25FU5QY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FU5QY worth?
The government has obligated $12,195 on SPE2DB25FU5QY.
Is contract SPE2DB25FU5QY an order under another contract?
Yes. SPE2DB25FU5QY is a delivery order under SPE2DB22D2108, an indefinite delivery contract.
Was contract SPE2DB25FU5QY competed?
The extent of competition for SPE2DB25FU5QY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award